Add The Wire As Your Trusted Source
For the best experience, open
https://m.thewire.in
on your mobile browser.
AdvertisementAdvertisement

Watch | Coronavirus Updates, April 24: Leaked Study Shows Remdesivir Ineffective Against COVID-19

A US company Gilead Sciences, however, has said that the data suggest that there is a “potential benefit.”
A US company Gilead Sciences, however, has said that the data suggest that there is a “potential benefit.”
watch   coronavirus updates  april 24  leaked study shows remdesivir ineffective against covid 19
Advertisement

The results of the clinical trials conducted on Remdesivir, the antiviral by Gilead Sciences shows that the drug fails to speed the improvement of patients with COVID-19 and doesn’t not prevent them from dying. The results of this clinical trial were long-awaited.

A US company Gilead Sciences, however, has said that the data suggest that there is a “potential benefit.”

According to reports, a draft document was accidentally posted on the website of the WHO and was removed later. It is unclear why this was done

Gilead spokesperson Amy Flood told the media that according to the company, the post on WHO’s website mischaracterised the study.

Advertisement

This article went live on April twenty-fifth, two thousand twenty, at twenty-five minutes past ten in the morning.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.

Advertisement
Advertisement
tlbr_img1 Series tlbr_img2 Columns tlbr_img3 Multimedia